-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $42

Benzinga·11/06/2026 19:46:02
Listen to the news
Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $45 to $42.